Form 4: Hims & Hers Health Chief Commercial Officer Executes Pre-Planned Stock Transactions

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., reported the exercise of stock options and subsequent sale of shares totaling 5,100 shares, all conducted under a Rule 10b5-1 trading plan.

Summary

• Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc. (HIMS), filed a Form 4 detailing recent equity transactions.
• On June 5, 2025, Mr. Chi exercised options to acquire 28,776 shares of Class A Common Stock at an exercise price of $13.9 per share.
• On June 6, 2025, Mr. Chi exercised options to acquire an additional 1,500 shares of Class A Common Stock at an exercise price of $11.53 per share.
• Also on June 6, 2025, Mr. Chi exercised options to acquire another 3,600 shares of Class A Common Stock at an exercise price of $13.9 per share.
• Following these exercises, Mr. Chi sold 1,500 shares of Class A Common Stock at a price of $56 per share on June 6, 2025.
• Concurrently, on June 6, 2025, Mr. Chi sold an additional 3,600 shares of Class A Common Stock at a price of $56 per share.
• All reported stock option exercises and sales were executed pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025.
• After these transactions, Mr. Chi directly beneficially owns 256,580 shares of Class A Common Stock.
• Mr. Chi also holds remaining derivative securities, including 15,000 stock options at an exercise price of $13.9, 11,400 stock options at an exercise price of $13.9, and 49,856 stock options at an exercise price of $11.53.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. While there are insider sales, they are part of a pre-arranged 10b5-1 plan, which is a common and expected practice for executive compensation and liquidity. The significant profit from option exercises is a positive for the executive.

Positives

• The exercise of stock options at significantly lower prices ($13.9 and $11.53) compared to the sale price ($56) indicates a substantial gain for the Chief Commercial Officer on these transactions.
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests a systematic approach to managing equity and not a reaction to new, negative information about the company.

Negatives

• The sale of 5,100 shares by a key executive, even if pre-planned, represents a reduction in direct insider ownership, which some investors might view with slight caution.

Future Outlook

NA

Industry Context

This Form 4 filing details routine insider equity transactions for an executive at Hims & Hers Health, Inc., a company operating in the telehealth and personal care industry. Such filings are standard disclosures and do not typically provide insights into broader industry trends or competitive dynamics, but rather reflect individual executive compensation and liquidity management.

Stakeholder Impact

• Shareholders may observe the Chief Commercial Officer's sale of shares, though the pre-planned nature via a Rule 10b5-1 plan mitigates concerns about its implications for company performance, suggesting it's a routine liquidity event rather than a signal of lack of confidence.

Key Dates

Recommendation

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Trading, Stock Options, Rule 10b5-1, Michael Chi, Chief Commercial Officer, Equity Transactions, Beneficial Ownership